Abstract
The prevalence of liver disease in the UK has increased substantially over recent decades, principally due to alcohol, non-alcoholic fatty liver disease associated with obesity, and viral hepatitis B and C. Liver cirrhosis may lead to the development of portal hypertension, which has a significant impact on patient outcomes and survival. These patients are clinically challenging and costly to manage, often requiring treatment for consequences of liver failure such as ascites, variceal haemorrhage, sepsis, and renal failure. Transjugular intrahepatic portosystemic shunt (TIPS) insertion offers a minimally invasive option for lowering raised portal pressure, which can provide symptomatic relief and confer a survival benefit in selected patients suffering the complications of portal hypertension. The first TIPS procedures were carried out in the 1980s, and success rates have increased as endovascular and radiological technologies have developed. There are, however, considerable challenges to delivering an effective TIPS service, including the organization of multidisciplinary input with appropriate anaesthetic expertise and support.
Keywords

This publication has 9 references indexed in Scilit: